Cyllene Therapeutics: Funding, Investors & Team (Sep 2026)
Cyllene Therapeutics is a French biotechnology business that is pioneering a novel approach termed pinpoint gene therapy.
Cyllene Therapeutics has raised $37.7M across 1 funding round on record, the most recent a Series C of $37.7M announced in Jul 2026.
That round is above the $7.0M median round size for France companies tracked on FundedIQ over the last two years.
Cyllene Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Cyllene Therapeutics Funding Rounds
Cyllene Therapeutics Investors
8 investors are recorded in total; the 5 named above are those the record identifies.
Cyllene Therapeutics Funding in Context
Cyllene Therapeutics' latest round of $37.7M is above the median round in France. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cyllene Therapeutics in Biotechnology and Paris
Companies Similar to Cyllene Therapeutics
Opio is a startup building specialized software to automate time-consuming financial due diligence (FDD)…
Hackuity provides a cybersecurity platform for identifying, prioritizing, and managing vulnerabilities.
Kaiko is a market data provider in the blockchain-based digital assets space, providing institutional…
Arlequin AI is a platform for social data analytics that provides services for transforming data, exploring…
Actionable is a startup that focuses on using artificial intelligence for predictive analysis of customer…
Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of…
Olenbee provides fintech solutions that integrate employee benefits into everyday card spending, covering…
Outline builds AI software to automate corporate budgeting, forecasting, and FP&A.
Mistral AI is a platform that assembles team to develop the generative AI models. It creates and offers…
Huscarl provides AI-native actuarial advisory and insurance analytics for corporate risk managers and finance…
ColibrITD is working on a framework that seeks to make Quantum Computing technology easily accessible to all…
ArcSpace creates electron beam welding technology for in orbit satellite repair and space infrastructure…
Cyllene Therapeutics Funding FAQs
What does Cyllene Therapeutics do?
Cyllene Therapeutics is a French biotechnology business that is pioneering a novel approach termed pinpoint gene therapy.
How much funding has Cyllene Therapeutics raised?
Cyllene Therapeutics has raised $37.7M across 1 round on record. The most recent is a Series C of $37.7M announced in Jul 2026.
When did Cyllene Therapeutics last raise funding?
Cyllene Therapeutics' most recent funding round on record is a Series C of $37.7M, announced in Jul 2026.
Who has invested in Cyllene Therapeutics?
Investors on record for Cyllene Therapeutics include Lamond Ventures, Bpifrance, Andera Partners, GordonMD Global Investments, M Ventures. FundedIQ records 8 investors in total.
Where is Cyllene Therapeutics headquartered?
Cyllene Therapeutics is based in Paris, France.
How many employees does Cyllene Therapeutics have?
Cyllene Therapeutics is in the 11-50 employee band.
When was Cyllene Therapeutics founded?
Cyllene Therapeutics was founded in 2019.
About FundedIQ's Cyllene Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cyllene Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.